Feedback / Questions
Elayta (CT1812) - Cognition Therap
https://www.globenewswire.com/news-release/2023/11/07/2774989/0/en/Cognition-Therapeutics-Completes-Enrollment-in-Phase-2-SHINE-Study-of-CT1812-in-Mild-to-Moderate-Alzheimer-s-Disease.html
Nov 7, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next